CYCLOGYL

This brand name is authorized in Canada, Cyprus, Estonia, Hong Kong, Lithuania, Netherlands, New Zealand, Singapore, United States

Active ingredients

The drug CYCLOGYL contains one active pharmaceutical ingredient (API):

1 Cyclopentolate UNII 736I6971TE - CYCLOPENTOLATE HYDROCHLORIDE

Cyclopentolate is an antimuscarinic agent used topically in the eye as a mydriatic and cycloplegic. The effects are similar to those of atropine, but with a more rapid onset and a shorter duration of action. Read about Cyclopentolate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01FA04	Cyclopentolate	S Sensory organs → S01 Ophthalmologicals → S01F Mydriatics and cycloplegics → S01FA Anticholinergics
Discover more medicines within S01FA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 00252506
Country: EE	Ravimiamet	Identifier(s): 1123760, 1863424
Country: HK	Department of Health Drug Office	Identifier(s): 25765
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1010022
Country: NL	Z-Index G-Standaard	Identifier(s): 12111651
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 4618
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 5911
Country: SG	Health Sciences Authority	Identifier(s): 04714P
Country: US	FDA, National Drug Code	Identifier(s): 0065-0395, 0065-0396, 0065-0397